PERSPECTIVE THERAPEUTICS, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$5.71 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-09-28
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$1.21M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$1.49M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$1.66M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$1.35M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$5.71M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$3.88M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$3.52M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$3.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$2.70M derived: sum of 2 quarters · filed 2017-09-28 | -$4.36M derived: sum of 3 quarters · filed 2017-09-28 | -$5.71M 10-K · filed 2017-09-28 | ||||
| 2017-03-31 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | -$3.15M derived: sum of 2 quarters · filed 2017-05-10 | -$4.50M 10-Q · filed 2017-05-10 | -$5.71M derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-12-31 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$3.01M 10-Q · filed 2017-02-09 | -$4.22M derived: sum of 3 quarters · filed 2017-09-28 | -$4.98M derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-09-30 | -$1.35M 10-Q · filed 2016-11-09 | -$2.56M derived: sum of 2 quarters · filed 2017-09-28 | -$3.32M derived: sum of 3 quarters · filed 2017-09-28 | -$4.13M derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-06-30 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$1.96M derived: sum of 2 quarters · filed 2017-09-28 | -$2.77M derived: sum of 3 quarters · filed 2017-09-28 | -$3.88M 10-K · filed 2017-09-28 | ||||
| 2016-03-31 | -$756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | -$1.57M derived: sum of 2 quarters · filed 2017-05-10 | -$2.68M 10-Q · filed 2017-05-10 | -$2.68M 10-Q · filed 2016-05-10 | -$3.31M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-12-31 | -$811.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$1.92M 10-Q · filed 2017-02-09 | -$1.92M 10-Q · filed 2016-02-09 | -$2.55M derived: sum of 3 quarters · filed 2017-09-28 | -$3.68M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-09-30 | -$1.11M 10-Q · filed 2016-11-09 | -$1.11M 10-Q · filed 2015-11-09 | -$1.74M derived: sum of 2 quarters · filed 2017-09-28 | -$2.87M derived: sum of 3 quarters · filed 2017-09-28 | -$3.49M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-06-30 | -$629.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$1.76M derived: sum of 2 quarters · filed 2017-09-28 | -$2.38M derived: sum of 3 quarters · filed 2017-09-28 | -$3.52M 10-K · filed 2017-09-28 | -$3.52M 10-K · filed 2015-09-14 | |||
| 2015-03-31 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | -$1.75M derived: sum of 2 quarters · filed 2016-05-10 | -$2.89M 10-Q · filed 2016-05-10 | -$3.88M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-12-31 | -$614.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | -$1.76M 10-Q · filed 2016-02-09 | -$2.75M derived: sum of 3 quarters · filed 2016-09-09 | -$3.25M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-09-30 | -$1.14M 10-Q · filed 2015-11-09 | -$2.13M derived: sum of 2 quarters · filed 2016-09-09 | -$2.63M derived: sum of 3 quarters · filed 2016-09-09 | -$3.48M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-06-30 | -$989.02K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | -$1.49M derived: sum of 2 quarters · filed 2016-09-09 | -$2.34M derived: sum of 3 quarters · filed 2016-09-09 | -$3.23M 10-K · filed 2016-09-09 | ||||
| 2014-03-31 | -$501.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$1.35M derived: sum of 2 quarters · filed 2015-05-15 | -$2.24M 10-Q · filed 2015-05-15 | -$3.03M derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-12-31 | -$845.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | -$1.74M 10-Q · filed 2015-02-17 | -$2.52M derived: sum of 3 quarters · filed 2015-09-14 | -$3.28M derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-09-30 | -$892.02K 10-Q · filed 2014-11-14 | -$1.68M derived: sum of 2 quarters · filed 2015-09-14 | -$2.44M derived: sum of 3 quarters · filed 2015-09-14 | |||||
| 2013-06-30 | -$786.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | -$1.54M derived: sum of 2 quarters · filed 2015-09-14 | -$3.06M 10-K · filed 2015-09-14 | |||||
| 2013-03-31 | -$756.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | -$2.27M 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | -$1.51M 10-Q · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |